Antimicrobial resistance in Neisseria gonorrhoeae.

The changing patterns of antimicrobial resistance in Neisseria gonorrhoeae have been reviewed regularly since the introduction of antimicrobial therapy in the 1930s. At present, ceftriaxone, fluoroquinolones, and spectinomycin have remained efficient as single-dose treatment of gonorrhea worldwide. To ensure that limited resources can be used in the best possible way, continuous surveillance of gonococcal resistance to antimicrobials is needed.

[1]  M. Chu,et al.  Epidemiology of penicillin-resistant Neisseria gonorrhoeae isolated in Taiwan, 1960-1990. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  S. Morse,et al.  High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant , 1986, Antimicrobial Agents and Chemotherapy.

[3]  F. Wignall,et al.  In vitro antibiotic susceptibilities of Neisseria gonorrhoeae isolates in the Philippines , 1992, Antimicrobial Agents and Chemotherapy.

[4]  D. Brown,et al.  Antimicrobial susceptibility testing of Neisseria gonorrhoeae: a trial organised as part of the United Kingdom national external quality assessment scheme for microbiology. , 1988, Journal of clinical pathology.

[5]  K. Holmes,et al.  Localized outbreak of penicillinase-producing Neisseria gonorrhoeae. Paradigm for introduction and spread of gonorrhea in a community. , 1989, JAMA.

[6]  M. Dessens-Kroon,et al.  INCREASED TETRACYCLINE RESISTANCE IN GONOCOCCI IN THE NETHERLANDS , 1989, The Lancet.

[7]  J. Dillon,et al.  Beta-lactamase plasmids and chromosomally mediated antibiotic resistance in pathogenic Neisseria species , 1989, Clinical Microbiology Reviews.

[8]  I. Phillips,et al.  Spectinomycin resistant gonococci. , 1983, British medical journal.

[9]  V. Hemming,et al.  PENICILUNASE-PRODUCING NEISSERIA GONORRHŒÆ , 1976, The Lancet.

[10]  I Lind,et al.  Epidemiology of antibiotic resistant Neisseria gonorrhoeae in industrialized and developing countries. , 1990, Scandinavian journal of infectious diseases. Supplementum.

[11]  C. Thornsberry,et al.  The National Gonorrhea Therapy Monitoring Study: I. Review of Treatment Results and of In‐vitro Antibiotic Susceptibility, 1972–1978 , 1979, Sexually transmitted diseases.

[12]  F. Wignall,et al.  ORAL ROSOXACIN FOR TREATMENT OF PENICILLIN-RESISTANT GONORRHOEA , 1984, The Lancet.

[13]  I. Lind,et al.  The Emergence of Penicillinase‐producing Neisseria gonorrhoeae Strains Carrying the 4.9 kb (Toronto) Plasmid in Denmark and of a Novel Large Plasmid in Two Nonpenicillinase‐producing Neisseria gonorrhoeae Strains , 1992, Sexually transmitted diseases.

[14]  C. Ison,et al.  Epidemiology of penicillin resistant Neisseria gonorrhoeae. , 1991, Genitourinary medicine.

[15]  E. Hook,et al.  Temporal Trends in Gonococcal Antibiotic Resistance in Baltimore , 1992, Sexually transmitted diseases.

[16]  J. Zenilman,et al.  Frequency and distribution in the United States of strains of Neisseria gonorrhoeae with plasmid-mediated, high-level resistance to tetracycline. , 1987, The Journal of infectious diseases.

[17]  J. Dillon,et al.  Effects of different media and methods of inoculum preparation on results of antimicrobial susceptibility testing of Neisseria gonorrhoeae by agar dilution , 1987, Antimicrobial Agents and Chemotherapy.

[18]  K. Holmes,et al.  Evaluation of Sampling Methods for Surveillance of Neisseria Gonorrhoeae Strain Populations , 1988 .

[19]  C. Thornsberry,et al.  SPECTINOMYCIN-RESISTANT PENICILLINASE-PRODUCING NEISSERIA GONORRHOEAE , 1981, The Lancet.

[20]  C. Genco,et al.  Acquisition of β-lactamase and TetM‐containing Conjugative Plasmids by Phenotypically Different Strains of Neisseria gonorrhoeae , 1990, Sexually transmitted diseases.

[21]  M. W. Bentzon,et al.  Spectinomycin hydrochloride (Trobicin) in the treatment of gonorrhoea. Observation of resistant strains of Neisseria gonorrhoeae. , 1973, The British journal of venereal diseases.

[22]  P. Sparling,et al.  A community-based outbreak of infection with penicillin-resistant Neisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance). , 1985, The New England journal of medicine.

[23]  P. Murray,et al.  Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae. , 1990, Diagnostic microbiology and infectious disease.

[24]  A. Meheus,et al.  Epidemiology of sexually transmitted diseases: the global picture. , 1990, Bulletin of the World Health Organization.

[25]  W. Shafer,et al.  Identification of an envelope mutation (env-10) resulting in increased antibiotic susceptibility and pyocin resistance in a clinical isolate of Neisseria gonorrhoeae , 1984, Antimicrobial Agents and Chemotherapy.

[26]  P. Murray,et al.  Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline , 1989, Journal of clinical microbiology.

[27]  Ian Phillips,et al.  &bgr;-LACTAMASE-PRODUCING, PENICILLIN-RESISTANT GONOCOCCUS , 1976, The Lancet.

[28]  C. Ison,et al.  Sampling methods for monitoring changes in gonococcal populations , 1989, Epidemiology and Infection.

[29]  J. Riou,et al.  The epidemiology of Neisseria gonorrhoeae isolates in Dakar, Sénégal 1982-1986: antimicrobial resistance, auxotypes and plasmid profiles. , 1991, Genitourinary medicine.

[30]  A. Evans,et al.  Prolonged use of the Greenland method of treatment of gonorrhoea. , 1980, The British journal of venereal diseases.

[31]  K. Kam,et al.  Patterns of Antibiotic Susceptibility of Gonococci Isolated in Hong Kong, 1987–1990 , 1992, Sexually transmitted diseases.

[32]  J. Tapsall,et al.  Characteristics of Neisseria Gonorrhoeae Isolated in Australia Showing Decreased Sensitivity to Quinolone Antibiotics , 1992, Pathology.

[33]  H. Handsfield,et al.  A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group. , 1991, The New England journal of medicine.

[34]  R. Willcox..  A survey of problems in the antibiotic treatment of gonorrhoea. With special reference to South-East Asia. , 1970, The British journal of venereal diseases.

[35]  H. Heffernan,et al.  Antibiotic susceptibilities, serotypes and auxotypes of Neisseria gonorrhoeae isolated in New Zealand. , 1992, Genitourinary medicine.

[36]  P. Sparling,et al.  Genetics of resistance in a non-beta-lactamase-producing gonococcus with relatively high-level penicillin resistance , 1986, Antimicrobial Agents and Chemotherapy.

[37]  K. Quitzau,et al.  Treating genitourinary and pharyngeal gonorrhoea with single dose ceftriaxone. , 1989, Genitourinary medicine.

[38]  I. Lind.  In-vitro susceptibility of Neisseria gonorrhoeae to thiamphenicol: results for selected groups of strains from different geographic areas and from different times. , 1984, Sexually transmitted diseases.

[39]  E. Dunlop.  GonorrhœA and the Sulphonamides* , 1949 .

[40]  J. Pépin,et al.  The dominance of a multiresistant strain of Neisseria gonorrhoeae among prostitutes and STD patients in The Gambia. , 1992, Genitourinary medicine.